| Date | Source | Headline |
|---|---|---|
| 19th Dec 2025 6:00 am | RNS | Egetis Therapeutics initiates New Drug Application in the USA for Emcitate® (tiratricol) for MCT8 deficiency |
| 19th Dec 2025 6:00 am | MFN | Egetis Therapeutics initiates New Drug Application in the USA for Emcitate® (tiratricol) for MCT8 deficiency |
| 25th Nov 2025 6:00 am | MFN | Interim report Q3 2025 |
| 14th Nov 2025 6:00 am | MFN | Egetis announces positive results from the ReTRIACt study of Emcitate® (tiratricol) in MCT8 deficiency |